# Nexalin Technology, Inc. (NXL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NXL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 15.0K | $ -2.10M | $ -1.76M | $ 0 | $ 2.89M |
| 2025 | $ 308.9K | $ -8.42M | $ -5.08M | $ 0 | $ 3.75M |
| 2024 | $ 177.3K | $ -8.00M | $ -4.16M | $ 0 | $ 3.68M |
| 2023 | $ 119.7K | $ -5.03M | $ -4.27M | $ 4.5K | $ 3.21M |
| 2022 | $ 1.48M | $ -1.92M | $ -2.48M | $ 755.3K | $ 5.48M |
| 2021 | $ 171.2K | $ -7.22M | $ -1.28M | $ 850.1K | $ -1.68M |
| 2020 | $ 309.5K | $ -4.34M | $ -1.10M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.28 |
| Current Ratio | 4.07 |

## Other views

- [Metrics](https://sponda.capital/en/NXL.md)
- [Charts](https://sponda.capital/en/NXL/charts.md)
- [Compare](https://sponda.capital/en/NXL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.